Last week, Russian President Vladimir Putin claimed the vaccine, developed by Moscow’s Gamaleya Institute along with the Defence Ministry, worked “quite effectively” and formed “stable immunity” against the disease.
Phase III trials to begin in 7-10 days According to the Tass news agency, the mandatory phase-III human trials of the Sputnik V vaccine would begin in 7-10 days and several tens of thousands of people would be vaccinated. The research will be conducted in the Moscow Region.
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines
READ THE ENTIRE ISSUE
September - October 2020